New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
06:34 EDTMWVMeadWestvaco downgraded to Neutral from Outperform at RW Baird
Baird downgraded MeadWestvaco due to fair valuation. The firm recommends swapping into Avery (AVY), which was upgraded to Outperform from Neutral, over MeadWestvaco (MWV). MeadWestvaco price target remains $40.
News For MWV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2015
08:34 EDTMWVHealthPrize Technologies and MeadWestvaco form strategic alliance
HealthPrize Technologies and MeadWestvaco announced a strategic collaboration to integrate their proven adherence solutions to provide an end-to-end program to pharmaceutical companies, pharmacy chains, and the patients they serve. MWV's innovative calendared medication packaging with its proven adherence benefits will feature a link to HealthPrize's Software-as-a-Service medication adherence and patient engagement platform.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use